In the present study, intraperitoneal administration of minocycline attenuated enhancing nociceptive behaviors in those rats receiving dual formalin injections (5% formalin followed at 7 days later by 1% formalin). The minocycline treatment did not prevent the increase in OX-42 and MHC class I labeling and morphological changes, but significantly attenuated upregulation of phospho-p38 in activated microglia. These results suggest that the later days of microglial activation with upregulated immune markers in the spinal cord contributes to enhancing long-term pain response by a pathway of p38 activation in microglia.
Introduction
There is increasing evidence that activated glia (microglia and astrocytes) in the spinal cord contribute to the induction and maintenance of pathological pain. Microglial activation has been described in several ways including changes in morphology, an increase in the expression of microglial markers, or the number of microglia. Changes in microglial morphology from ramified to amoeboid were evident at 2-3 days after peripheral tissue injury (Coyle, 1998; Fu et al., 1999; Graeber et al., 1988; Hashizume et al., 2000; Honore et al., 2000; Lin et al., 2007b; Molander et al., 1997) . In our previous study, peripheral formalin injection upregulated the expression of CD45 and MHC class I antigen in activated microglia, beginning 3 days after the formalin injection and up to at least day 7 (Fu et al., 2009 ). The time course of these immune marker changes corresponded with that of changes in microglial morphology detected by OX-42 immunohistochemistry (Fu et al., 1999) . Moreover, while microglia undergo an early and rapid activation without observable morphological changes (Hua et al., 2005; Svensson et al., 2003) , changes in both morphology and immune markers are observed only at a late stage (days to weeks) after tissue injury (Fu et al., 2009 ). Thus, microglia may undergo two distinct stages of changes after tissue injury (Fu et al., 2009 ): (1) Early-activated microglia indicated by phospho-p38MAPK still have a "resting" ramified morphology with a relatively small cell body and weakly express molecules normally present in other haematopoietic lineages, such as CD45, MHC class I antigen, and other immunomolecules. (2) Lateactivated microglia show upregulation of CD45 and MHC class I as well as morphology characterized by a hypertrophic cell body and the shortening of cellular processes.
Glial cells, upon activation, are the source of a number of neuromodulators such as pro-inflammatory cytokines, chemokines, nitric oxide, prostaglandins and ATP, contributing to the mechanisms of central sensitization (De Leo et al., 2006; Marchand et al., 2009; McMahon et al., 2005; Moalem and Tracey, 2006; Owolabi and Saab, 2006; Watkins et al., 2007) . The morphological differences may relate to the function of microglia at different times following peripheral injury. For example, each stage of activated microglia may produce and release different neuromodulators and differentially contribute to nociceptive behaviors. If so, it would be possible for microglial activation with or without changes in morphology and immune markers to contribute differently to nociceptive behavior induced by the formalin injection into a rat's hindpaw.
Minocycline, a tetracycline-like anti-biotic, has been used as a microglial activation inhibitor and shown to ameliorate several neurodegenerative conditions (Hua and Walz, 2006; Ravina et al., 2003; Tikka and Koistinaho, 2001; Yong et al., 2004) . Systemic or spinal injections of minocycline have been shown to attenuate neuropathic Journal of Neuroimmunology 221 (2010) [25] [26] [27] [28] [29] [30] [31] 
